These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 1915104
1. Skeletal effects of calcitonin in ovariectomized rats. Wronski TJ, Yen CF, Burton KW, Mehta RC, Newman PS, Soltis EE, DeLuca PP. Endocrinology; 1991 Oct; 129(4):2246-50. PubMed ID: 1915104 [Abstract] [Full Text] [Related]
2. Skeletal effects of calcitonin treatment and withdrawal in ovariectomized rats. Shen Y, Li M, Wronski TJ. Calcif Tissue Int; 1996 Apr; 58(4):263-7. PubMed ID: 8661958 [Abstract] [Full Text] [Related]
3. Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats. Shen Y, Li M, Wronski TJ. Calcif Tissue Int; 1997 May; 60(5):457-61. PubMed ID: 9115164 [Abstract] [Full Text] [Related]
4. A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats. Li M, Shen Y, Burton KW, DeLuca PP, Mehta RC, Baumann BD, Wronski TJ. Bone; 1996 Apr; 18(4):375-80. PubMed ID: 8726397 [Abstract] [Full Text] [Related]
5. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Wronski TJ, Cintrón M, Doherty AL, Dann LM. Endocrinology; 1988 Aug; 123(2):681-6. PubMed ID: 3396505 [Abstract] [Full Text] [Related]
6. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats. Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L. J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862 [Abstract] [Full Text] [Related]
7. Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Liang H, Pun S, Wronski TJ. Endocrinology; 1999 Dec; 140(12):5780-8. PubMed ID: 10579344 [Abstract] [Full Text] [Related]
8. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice. Iwaniec UT, Yuan D, Power RA, Wronski TJ. J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527 [Abstract] [Full Text] [Related]
12. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Wronski TJ, Dann LM, Scott KS, Crooke LR. Endocrinology; 1989 Aug; 125(2):810-6. PubMed ID: 2502377 [Abstract] [Full Text] [Related]
13. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD. Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465 [Abstract] [Full Text] [Related]
14. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat. Erben RG, Bante U, Birner H, Stangassinger M. Calcif Tissue Int; 1997 May; 60(5):434-40. PubMed ID: 9115161 [Abstract] [Full Text] [Related]
16. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Wronski TJ, Yen CF, Qi H, Dann LM. Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497 [Abstract] [Full Text] [Related]